VRNA - Margin resik Verona Pharma plc

Verona Pharma PLC (VRNA) - logo korporat

The net margin dynamics of Verona Pharma plc (VRNA) reflect the company's dependence on FDA approval and patent protection. Logistic complexities stemming from global conflicts create risks, although a focus on Western markets stabilizes the environment. The current profitability trend is visible on this chart, where -36.40 serves as the current parameter value, helping to assess product implementation efficiency.

Rentabilitas dodolan resik Verona Pharma Inc. (VRNA): kanggo periode 04.07.2022 - 18.10.2025

Verona Pharma Inc. (VRNA) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
Analisis umum perusahaan:Verona Pharma - VRNA
Produk dadi Verona Pharma Corp

Sales margins determine the share of net profit in every ruble of revenue, measuring cost management efficiency and the ultimate profitability of the business. An analysis of the net margin of commercial activities allows for an assessment of the potential of Verona Pharma plc (VRNA): following the completion of costly clinical trials, the low cost of drug synthesis during mass distribution should ensure a sharp increase in this indicator.

Karo sapa Verona Pharma plc saingan

HLN: Margin dodolan resik|Rentabilitas dodolan resik KVUE|Margin resik Jyong Biotech Ltd|Margin dodolan resik Ligand Corp|Margin dodolan resik AMRX|Margin dodolan perusahaan Perrigo Company plc|Margin dodolan resik ALVO (Alvotech Biopharmaceuticals)|LQDA: Rentabilitas dodolan resik|Galapagos N.V. - Margin dodolan resik|ANIP - Margin dodolan resik|MNKD: Margin dodolan resik|amphastar.com (AMPH) - Margin dodolan resik|PCRX (Pacira Pharmaceuticals) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik ARS Pharmaceuticals, Inc. (SPRY)|Margin dodolan resik TBPH|AQST (Aquestive Therapeutics) - Tingkat bathi resik|scPharmaceuticals, Inc. - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik TECX|tonixpharma.com - Margin dodolan resik|Tingkat bathi resik SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Margin resik|Rentabilitas dodolan miturut bathi resik BioHarvest|Rentabilitas dodolan miturut bathi resik EXOZ|Rentabilitas dodolan miturut bathi resik Oramed Pharmaceuticals (ORMP)|Rentabilitas dodolan miturut bathi resik ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Rentabilitas dodolan resik|Margin dodolan resik ABVC (ABVC BioPharma Inc)|CPIX - Rentabilitas dodolan miturut bathi resik|Quantum BioPharma Corp - Margin dodolan resik|FGEN (fibrogen.com) - Rentabilitas dodolan resik|TELO (Telomir Pharmaceuticals) - Rentabilitas dodolan miturut bathi resik|Rani Therapeutics Holdings - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik SNYR|Margin resik rallybio.com RLYB|Margin dodolan resik LEXX|PULM (Pulmatrix, Inc.) - Tingkat bathi resik|Pheton Holdings - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik Aptorum Group Limited APM|LYRA: Rentabilitas dodolan miturut bathi resik|IBO: Margin resik|TNFA: Margin dodolan resik|YCBD: Rentabilitas resik perusahaan|Margin resik PainReform Ltd|CYTO (altamiratherapeutics.com) - Rentabilitas resik perusahaan|Margin dodolan resik LIPO|OPTN - Margin resik|Margin resik pieris.com PIRS|Tingkat bathi resik PROC|PTPI - Margin resik|Qilian International Holding (QLI) - Rentabilitas dodolan miturut bathi resik|SLRN: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik TFF Pharma